ATE123028T1 - Phospholipase-a2-inhibitor, verfahren zu seiner herstellung und diesen enthaltende pharmazeutische oder veterinäre zusammensetzungen. - Google Patents
Phospholipase-a2-inhibitor, verfahren zu seiner herstellung und diesen enthaltende pharmazeutische oder veterinäre zusammensetzungen.Info
- Publication number
- ATE123028T1 ATE123028T1 AT90304552T AT90304552T ATE123028T1 AT E123028 T1 ATE123028 T1 AT E123028T1 AT 90304552 T AT90304552 T AT 90304552T AT 90304552 T AT90304552 T AT 90304552T AT E123028 T1 ATE123028 T1 AT E123028T1
- Authority
- AT
- Austria
- Prior art keywords
- phospholipase
- inhibitor
- compound
- production
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Botany (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1109939A JP2842613B2 (ja) | 1989-04-28 | 1989-04-28 | フォスフォリパーゼa▲下2▼阻害物質 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE123028T1 true ATE123028T1 (de) | 1995-06-15 |
Family
ID=14522941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90304552T ATE123028T1 (de) | 1989-04-28 | 1990-04-26 | Phospholipase-a2-inhibitor, verfahren zu seiner herstellung und diesen enthaltende pharmazeutische oder veterinäre zusammensetzungen. |
Country Status (7)
Country | Link |
---|---|
US (1) | US5011952A (de) |
EP (1) | EP0395418B1 (de) |
JP (1) | JP2842613B2 (de) |
AT (1) | ATE123028T1 (de) |
DE (1) | DE69019591T2 (de) |
DK (1) | DK0395418T3 (de) |
ES (1) | ES2075154T3 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0547231T3 (da) * | 1991-07-03 | 1996-09-16 | Shionogi & Co | Phospholipase-A2-inhibitor |
CA2100640A1 (en) * | 1992-07-23 | 1994-01-24 | Shigeru Matsutani | Substitute benzoate derivatives |
GB9226724D0 (en) * | 1992-12-22 | 1993-02-17 | Xenova Ltd | Pharmaceutical compounds |
-
1989
- 1989-04-28 JP JP1109939A patent/JP2842613B2/ja not_active Expired - Fee Related
-
1990
- 1990-04-26 EP EP90304552A patent/EP0395418B1/de not_active Expired - Lifetime
- 1990-04-26 DK DK90304552.4T patent/DK0395418T3/da active
- 1990-04-26 DE DE69019591T patent/DE69019591T2/de not_active Expired - Fee Related
- 1990-04-26 AT AT90304552T patent/ATE123028T1/de not_active IP Right Cessation
- 1990-04-26 ES ES90304552T patent/ES2075154T3/es not_active Expired - Lifetime
- 1990-04-30 US US07/516,982 patent/US5011952A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2842613B2 (ja) | 1999-01-06 |
US5011952A (en) | 1991-04-30 |
EP0395418A1 (de) | 1990-10-31 |
DK0395418T3 (da) | 1995-08-07 |
EP0395418B1 (de) | 1995-05-24 |
DE69019591D1 (de) | 1995-06-29 |
JPH02286088A (ja) | 1990-11-26 |
DE69019591T2 (de) | 1996-01-25 |
ES2075154T3 (es) | 1995-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE121091T1 (de) | Phospholipase a2-inhibitor, mikroorganismen, die diesen inhibitor erzeugen und mehrere verfahren zu seiner herstellung. | |
AU643489B2 (en) | Antibacterial agents - II | |
HUT56379A (en) | Process for producing a-norsteroid-3-carboxylic acid derivatives and compositions comprising such compounds | |
ATE181074T1 (de) | Vinylen-azaindolderivate und verfahren zu ihrer herstellung | |
ATE135712T1 (de) | Polypeptid, dessen verfahren zur herstellung und dieses enthaltende pharmazeutische zusammensetzung und deren benutzung | |
ATE52500T1 (de) | Cyclohexenol-derivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses. | |
ATE211474T1 (de) | Galanthamin derivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente | |
AT380471B (de) | Verfahren zur herstellung von neuen 2-oxoazetidin-derivate | |
IL75116A (en) | Ethyl substituted-beta-carboxylates,process for the preparation thereof and pharmaceutical compositions containing the same | |
DE69106003D1 (de) | Verfahren und zwischenprodukte zur herstellung von azabicyclo[2.2.2]octan-3-iminen. | |
ATE123028T1 (de) | Phospholipase-a2-inhibitor, verfahren zu seiner herstellung und diesen enthaltende pharmazeutische oder veterinäre zusammensetzungen. | |
ATE214051T1 (de) | Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
ATE229006T1 (de) | Verfahren zur herstellung von schwefelhaltigen imidazolderivaten und erhaltene zwischenprodukte | |
ATE173922T1 (de) | 2-arylpropionsäure-zubereitungen und verfahren zu ihrer herstellung | |
ATE236895T1 (de) | Ringannelierte dihydropyrane, verfahren zur herstellung sowie deren verwendung | |
DE59010896D1 (de) | Verfahren zur Herstellung von 7-(3-Amino- sowie 3-Aminomethyl-1-pyrrolidinyl)-3-chinolon-carbonsäuren sowie -naphthyridoncarbonsäuren | |
BR9605027A (pt) | Processo para preparar um carboxilato de b-trifluor-metila & b-insaturado | |
ATE224393T1 (de) | Verfahren zur herstellung von cephalosporinen und zwischenverbindungen in diesem verfahren | |
DE69332707D1 (de) | Verfahren zur Herstellung von 3-Vinylcephalosporinen | |
SE7906681L (sv) | Ftalazonderivat | |
DE69905218D1 (de) | Verfahren zur Herstellung von L-Allysin Acetal | |
DE69615869D1 (de) | Eine zusammensetzung und ein verfahren zur foerderung der pflanzenproduktion und/oser zur eliminierung von unguenstigen umwelteinfluessen bei der pflanzenzucht | |
DE3882654D1 (de) | Enzymhemmer und methode zu dessen herstellung. | |
ATE16696T1 (de) | Verfahren zur herstellung von 3-alkyl-6-methylbeta-resorcylsaeureestern. | |
ATE179417T1 (de) | Glyceraldehyd-3-pentanid und verfahren zu ihrer herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |